{"organizations": [], "uuid": "02c32c52fbe6d698cda2da8e773268c2ecd2b5ac", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pfizer-canada-says-besponsa-approv/brief-pfizer-canada-says-besponsa-approved-by-health-canada-for-treating-adults-with-a-type-of-leukemia-idUSFWN1RJ0GN", "country": "US", "domain_rank": 408, "title": "BRIEF-Pfizer Canada Says BESPONSA Approved By Health Canada For Treating Adults With A Type Of Leukemia", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-06T22:06:00.000+03:00", "replies_count": 0, "uuid": "02c32c52fbe6d698cda2da8e773268c2ecd2b5ac"}, "author": "", "url": "https://www.reuters.com/article/brief-pfizer-canada-says-besponsa-approv/brief-pfizer-canada-says-besponsa-approved-by-health-canada-for-treating-adults-with-a-type-of-leukemia-idUSFWN1RJ0GN", "ord_in_thread": 0, "title": "BRIEF-Pfizer Canada Says BESPONSA Approved By Health Canada For Treating Adults With A Type Of Leukemia", "locations": [], "entities": {"persons": [{"name": "healt", "sentiment": "negative"}, {"name": "besponsa", "sentiment": "none"}], "locations": [{"name": "canada", "sentiment": "none"}, {"name": "canada", "sentiment": "none"}], "organizations": [{"name": "brief-pfizer canada says besponsa approved by health canada", "sentiment": "negative"}, {"name": "brief-pfizer canada says besponsa", "sentiment": "negative"}, {"name": "type of leukemia reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "pfizer canada inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 6, 2018 / 7:06 PM / Updated 11 minutes ago BRIEF-Pfizer Canada Says BESPONSA Approved By Health Canada For Treating Adults With A Type Of Leukemia Reuters Staff 1 Min Read \nApril 6 (Reuters) - Pfizer Canada Inc: \n* PFIZER CANADA SAYS BESPONSA APPROVED BY HEALTH CANADA FOR TREATING ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-06T22:06:00.000+03:00", "crawled": "2018-04-06T22:29:16.003+03:00", "highlightTitle": ""}